FLOW-Finding Lasting Options for Women - Full Text View

Purpose

Purpose: To compare the use of the menstrual cup “The DivaCupTM ” to a menstrual strategy using tampons as the primary method of menstrual flow management using indicators of user-satisfaction, urinary tract infection, vaginal irritation, cost and waste.
Hypothesis: The “The DivaCupTM” will have similar rates of user-satisfaction, urinary tract infection, and vaginal irritation as a menstrual strategy using tampons as the primary method of menstrual flow management but will likely be more reasonable in terms of cost and will generate less waste.

Condition	Intervention
Menstruation	Device: Diva Cup TM

MedlinePlus related topics:

Menstruation

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training, Randomized, Open Label, Historical Control, Parallel Assignment, Efficacy Study

Official Title:	FLOW-Finding Lasting Options for Women: A Prospective, Randomized, Multicenter Trial Comparing Tampons to a Menstrual Cup

Further study details as provided by University of British Columbia:

Primary Outcome Measures:

Overall satisfaction with menstrual strategy.

Secondary Outcome Measures:

Diagnosed UTI
Diagnosed vaginitis
Vaginal irritation
Waste
Cost

Estimated Enrollment:	100
Study Start Date:	November 2006
Estimated Study Completion Date:	April 2007

Detailed Description:

Method:

Prospective study of 100 women from family practice offices in Vancouver, Victoria and Prince George who currently use tampons to manage menstrual flow. After an information session and consent, subjects will be randomized to tampon use or Diva Cup use and record their experience on a diary for 3 months. Women who attend the information session and who do not enrol, or those who drop out will be asked their reasons for discontinuing, and their pre-study questionnaire will be used for analysis.

Eligibility

Ages Eligible for Study:	19 Years to 40 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Women between the ages of 19 and 40 who have menstrual flow most months and who currently self-identify as using tampons as their primary method of menstrual management

Exclusion Criteria:

Have a sensitivity or allergy to silicone
Have an active vaginal or urogenital infection
Are pregnant, or who have plans to become pregnant before spring 2007 (end of study data collection)
Have used systemic antimicrobials within the previous 14 days
Are unable to understand the nature and purpose of the study
Are unable to understand and express themselves in written and spoken English

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00397202

Contacts


Contact: Konia Trouton	250 480 7333	ktrouton@uvic.ca

Locations


Canada, British Columbia
	Private family physician offices	Recruiting
	Victoria, Vancouver, Prince George, British Columbia, Canada
	Contact: Konia Trouton, MD ktrouton@uvic.ca
	Principal Investigator: Konia Trouton, MD
	Principal Investigator: Courtney Howard, MD

Sponsors and Collaborators

University of British Columbia

National Research System-College of Family Physicians of Canada

Investigators


Principal Investigator:	Konia Trouton, MD	University of British Columbia

More Information

Study ID Numbers:	C06-0478
First Received:	November 6, 2006
Last Updated:	November 22, 2006
ClinicalTrials.gov Identifier:	NCT00397202
Health Authority:	Canada: Health Canada

Keywords provided by University of British Columbia:

Menstruation

Study placed in the following topic categories:

Signs and Symptoms

ClinicalTrials.gov processed this record on September 05, 2008

Sponsors and Collaborators:	University of British Columbia National Research System-College of Family Physicians of Canada
Information provided by:	University of British Columbia
ClinicalTrials.gov Identifier:	NCT00397202